CGEN (CGEN) Stock Price & Analysis
CGEN (CGEN) rose 1.37% to USD 2.59 as of September 8, 2026 at 09:03 UTC, according to Nexqual real-time market data.
CGEN last closed at USD 2.59; the session ranged USD 2.54–2.61 on volume of 199,695 shares. Market capitalization is —, with a 52-week range of USD 1.3–3.24 (NCM). Source: Nexqual, September 8, 2026 at 09:03 UTC.
Key Statistics (as of September 8, 2026 at 09:03 UTC)
| Price | USD 2.59 |
|---|---|
| Change | ▲ 1.37% (up) |
| Previous Close | USD 2.59 |
| Open | USD 2.59 |
| Day Range | USD 2.54 – 2.61 |
| 52-Week Range | USD 1.3 – 3.24 |
| Volume | 199,695 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (CGEN)
Nexqual's technical model rates CGEN "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 09:03 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 51.37 (neutral) |
| vs SMA50 | Above (USD 2.42) |
| MACD | 0.07 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CERS | Cerus Corporation | USD 2.59 | ▼ 0.38% |
| SYRS | Syros Pharmaceuticals, Inc. | USD 0 | ▲ 0% |
| VCYT | Veracyte, Inc. | USD 42.53 | ▼ 5.24% |
| MCRB | Seres Therapeutics, Inc. | USD 5.72 | ▲ 3.25% |
| EVGN | Evogene Ltd. | USD 0.54 | ▼ 0.37% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:03 UTC. This page is informational and not investment advice.